Oncocyte Corp Annual Depreciation in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Oncocyte Corp quarterly/annual Depreciation history and growth rate from 2014 to 2022.
  • Oncocyte Corp Depreciation for the quarter ending March 31, 2023 was $450K, a 56.8% increase year-over-year.
  • Oncocyte Corp annual Depreciation for 2022 was $1.53M, a 81% increase from 2021.
  • Oncocyte Corp annual Depreciation for 2021 was $844K, a 170% increase from 2020.
  • Oncocyte Corp annual Depreciation for 2020 was $313K, a 9.01% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.53M +$684K +81% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-12
2021 $844K +$531K +170% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $313K -$31K -9.01% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $344K -$94K -21.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
2018 $438K +$100K +29.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $338K +$193K +133% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $145K +$104K +254% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $41K +$2K +5.13% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $39K Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.